Literature DB >> 27264047

Gastrin regulates ABCG2 to promote the migration, invasion and side populations in pancreatic cancer cells via activation of NF-κB signaling.

Juan Wang1, Beibei Xin1, Hui Wang1, Xiaodan He1, Wei Wei2, Ti Zhang2, Xiaohong Shen3.   

Abstract

Gastrin is absent in most normal adult pancreatic tissues but is highly expressed in pancreatic cancer tissues. Although Gastrin expression was reported to be associated with tumor proliferation in human pancreatic cancer, studies on the relationship between Gastrin and tumor metastasis in pancreatic cancer are rare. In this study, we performed an analysis to determine the effects of Gastrin on modulating the side populations, cell proportion and tumor cell metastatic potential and invasion activity and explored its mechanisms in pancreatic cancer. We indicated that Gastrin and ABCG2 were widely expressed in pancreatic cancer cell lines and overexpressed in cancer tissues. Gastrin induced ABCG2 expression, and this effect was mediated by NF-κB activation. Gastrin regulated the SP proportion of BxPC-3 cells via modulating ABCG2 expression. Through the regulation of the functions of NF-κB/ABCG2, Gastrin functionally promoted the migration and invasion in pancreatic cancer cell. The present study indicated that Gastrin induced ABCG2 expression by activating NF-κB and thereby modulated the SP proportion, tumor cell metastatic potential and invasion activity in pancreatic cancer. Gastrin could serve as an effective therapeutic target for the metastasis of pancreatic cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABCG2; Gastrin; Pancreatic cancer; Side population cell

Mesh:

Substances:

Year:  2016        PMID: 27264047     DOI: 10.1016/j.yexcr.2016.06.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer.

Authors:  Yan Liu; Meng Gao; Juan An; Xin Wang; Yan Jia; Junfeng Xu; Jihai Zhu; Jiantao Cui; Wenmei Li; Rui Xing; Li Song; Kejia Liu; Yuqi He; Jianqiu Sheng; Shengmei Qi; Yuanming Pan; Youyong Lu
Journal:  Onco Targets Ther       Date:  2020-08-25       Impact factor: 4.147

2.  HNRNPA2B1 regulates the epithelial-mesenchymal transition in pancreatic cancer cells through the ERK/snail signalling pathway.

Authors:  Shengjie Dai; Bicheng Chen; Mengtao Zhou; Jie Zhang; Shihao Huang; Bin Lou; Binbo Fang; Tingting Ye; Xince Huang
Journal:  Cancer Cell Int       Date:  2017-01-10       Impact factor: 5.722

3.  PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1.

Authors:  Zhihua Ye; Yingyu Yang; Ying Wei; Lamei Li; Xinyi Wang; Junkai Zhang
Journal:  Cell Death Dis       Date:  2022-07-21       Impact factor: 9.685

4.  An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.

Authors:  Xiang Ling; Wenjie Wu; Chuandong Fan; Chao Xu; Jianqun Liao; Laurie J Rich; Ruea-Yea Huang; Elizabeth A Repasky; Xinjiang Wang; Fengzhi Li
Journal:  J Exp Clin Cancer Res       Date:  2018-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.